AJCP / Meeting AbstrActs and annotations to the slides. Residents were able to generate links to the scanned slides and share them via email, text messaging, and various social media platforms. Slides were capable of being viewed on multiple devices, such as desktop computers, mobile phones, and tablets. In the near future, a completely digital workflow may be on the horizon. The ViewsIQ software allows for an interactive educational experience where questions and comments can be left to be answered by any other viewer or educator. The utilization of this readily accessible training tool can provide educators an innovative way to reinforce and facilitate how pathology is taught.
Introduction:
The latest competency profile for students enrolled in Canadian Medical Association-accredited clinical genetics technology programs, effective 2015, include the understanding of next-generation sequencing (NGS) technology. NGS is a form of massively parallel sequencing, and the implementation of NGS has advanced rapidly in clinical genetics. Many health care institutions have introduced NGS workflows to deliver multi-gene test results. This has created a need to teach technical and analytical components to student technologists as they embark on a career where demand for NGS testing will substantially increase. Methods: The Advanced Molecular Diagnostics Laboratory (AMDL) located in the Princess Margaret Cancer Centre designed a half-day workshop on NGS analysis for genetics technology students at the Michener Institute, which offers one of two accredited clinical genetics programs in Canada. The application of NGS testing has become multidisciplinary; technologists have had to adapt to working with bioinformaticians and variant annotation specialists, and learn a multitude of laboratory skills in between. Program instructors at the Michener Institute decided to showcase the evolving role of genetics technologists by inviting AMDL to deliver a workshop focused on (1) data generation from the sequencer, (2) the use of genetic software, and (3) the basic understanding of variant detection and clinical implications. The workshop concluded with provision of examples for students to practice variant calling, reflecting real case scenarios from technologists' perspective. Conclusion: This is the second year AMDL presented to students; feedback confirmed strong interest in gaining practical exposure to NGS applications, and identified needed improvements to bridge gaps between teaching the use of advanced software and manual sequencing analysis. Student evaluations further reflect usefulness in reviewing NGS data types, but equal interest to learn fundamentals of variant interpretation. The overall reception supports a prerequisite for new technologists to embrace clinical NGS.
PCR Testing for Microorganism Detection: Yea or Nay?

Tiffany Graham, Peter Pavlidakey, MD; University of Alabama at Birmingham, Birmingham
Background: There is an ever-increasing demand for pathologists to minimize unnecessary testing while performing requests for complex molecular studies. Understanding the efficacy of a test and its role in guiding clinical practice decisions is essential. Herein, we analyze the utility of polymerase chain reaction (PCR) testing for speciation of microorganisms. Methods: We retrospectively reviewed our pathology database for cases from 2015 to 2017 with PCR tests requesting bacterial sequencing, fungal sequencing, or the detection of AFB be performed. The type, number, and final result of the PCR tests were determined. Positive cases were further examined for pathologic findings. Results: Thirty cases were sent for PCR analysis with an average of 2.9 tests ordered per case. A total of 88 tests were performed, aimed at the detection of mycobacterium tuberculosis (TB) (23/88; 26.1%), non-TB mycobacterium (21/88; 23.9%), bacteria (20/88; 22.7%), fungal organisms (17/88; 19.3%) or "other" (7/88; 8.0%) . A positive test result was identified in four cases (4/30 [13.3%]; 4/88 [4.5%]), which included 2/21 (9.5%) non-TB mycobacterium tests, 1/17 (5.9%) fungal tests, and 1/23 (4.3%) mycobacterium TB tests, for an overall positivity rate of 2.3%, 1.1%, and 1.1%, respectively. Of those cases with a positive result, an average of 2.5 tests were ordered, for an average positivity rate of 43.8% per case, or 2.8% overall. All cases displayed a dense inflammatory reaction pattern +/-granulomas and microorganisms were appreciated in three of four (75%) cases via special stains. Conclusion: The utilization of routine H&E, special stains, and microbiology cultures are sufficient to guide the clinical management of a patient with suspected infection. PCR testing can provide additional information; however, it is best left to the discretion of the clinician, as he or she can determine if it will adequately change management, given the low yield.
